BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Sgadari C, Scoppio B, Picconi O, et al. (2024) Clinical Efficacy of the HIV Protease Inhibitor Indinavir in Combination with Chemotherapy for Advanced Classic Kaposi Sarcoma Treatment: A Single-Arm, Phase II Trial in the Elderly. Cancer Research Communications. 4: 2112-2122 |
| Cafaro A, Schietroma I, Sernicola L, et al. (2024) Role of HIV-1 Tat Protein Interactions with Host Receptors in HIV Infection and Pathogenesis. International Journal of Molecular Sciences. 25 |
| Cafaro A, Ensoli B. (2022) HIV-1 therapeutic vaccines in clinical development to intensify or replace antiretroviral therapy: the promising results of the Tat vaccine. Expert Review of Vaccines. 1-11 |
| Ensoli B, Moretti S, Borsetti A, et al. (2021) New insights into pathogenesis point to HIV-1 Tat as a key vaccine target. Archives of Virology |
| Tripiciano A, Picconi O, Moretti S, et al. (2021) Anti-Tat immunity defines CD4 T-cell dynamics in people living with HIV on long-term cART. Ebiomedicine. 66: 103306 |
| Cafaro A, Barillari G, Moretti S, et al. (2020) HIV-1 Tat Protein Enters Dysfunctional Endothelial Cells via Integrins and Renders Them Permissive to Virus Replication. International Journal of Molecular Sciences. 22 |
| Qiu Y, Maione F, Capano S, et al. (2020) HIV-protease inhibitors block HPV16-induced murine cervical carcinoma and promote vessel normalization in association with MMP-9 inhibition and TIMP-3 induction. Molecular Cancer Therapeutics |
| Nicoli F, Gallerani E, Sicurella M, et al. (2020) The Tat Protein of HIV-1 Prevents the Loss of HSV-Specific Memory Adaptive Responses and Favors the Control of Viral Reactivation. Vaccines. 8 |
| Maggiorella MT, Sanarico N, Brindicci G, et al. (2020) High HIV-1 diversity in immigrants resident in Italy (2008-2017). Scientific Reports. 10: 3226 |
| Moretti S, Cafaro A, Tripiciano A, et al. (2020) HIV therapeutic vaccines aimed at intensifying combination antiretroviral therapy. Expert Review of Vaccines. 1-14 |